Innovative Imaging Solutions Median Technologies offers advanced AI-powered medical imaging solutions, including software as medical devices (SaMD) like eyonis, which provides significant opportunities to collaborate with biopharmaceutical companies and healthcare providers looking to incorporate cutting-edge diagnostic tools and improve early disease detection.

Growing Market Presence With recent participation in prominent healthcare conferences such as RSNA and ASCO, as well as strategic integrations like with Tempus, Median is actively expanding its visibility and building credibility among key stakeholders, opening doors for partnerships in clinical trials, imaging analysis, and diagnostics.

Expansion into AI Development Median’s focus on developing AI models for detecting pulmonary nodules and lung cancer screening indicates opportunities to sell specialized AI solutions and services to hospitals, radiology centers, and diagnostic labs seeking to adopt or enhance AI-driven workflows.

Strong Industry Credentials Being recognized as an innovative company and listed on Euronext enhances its appeal to healthcare organizations and investors, creating opportunities for strategic alliances, co-development projects, and procurement of larger-scale contracts in medical imaging and clinical trials.

Potential for Market Expansion With subsidiaries in the US and China, Median has the geographical scope to target international healthcare markets and global biopharmaceutical firms, providing tailored imaging and AI services across different regulatory environments, thereby increasing sales opportunities across multiple regions.